Avidity Biosciences Valuation
| RNA Stock | USD 43.25 0.69 1.62% |
At this time, the firm appears to be overvalued. Avidity Biosciences shows a prevailing Real Value of $36.7 per share. The current price of the firm is $43.25. Our model approximates the value of Avidity Biosciences from analyzing the firm fundamentals such as Return On Equity of -0.28, operating margin of (42.01) %, and Shares Outstanding of 119.31 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Avidity Biosciences' valuation include:
Price Book 3.3776 | Enterprise Value 3.5 B | Enterprise Value Ebitda (5.72) | Price Sales 501.9068 | Enterprise Value Revenue 345.6373 |
Overvalued
Today
Please note that Avidity Biosciences' price fluctuation is not too volatile at this time. Calculation of the real value of Avidity Biosciences is based on 3 months time horizon. Increasing Avidity Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Avidity Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avidity Stock. However, Avidity Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 43.25 | Real 36.7 | Target 36.0 | Hype 42.57 | Naive 40.14 |
The real value of Avidity Stock, also known as its intrinsic value, is the underlying worth of Avidity Biosciences Company, which is reflected in its stock price. It is based on Avidity Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Avidity Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Avidity Biosciences helps investors to forecast how Avidity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avidity Biosciences more accurately as focusing exclusively on Avidity Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Avidity Biosciences' intrinsic value based on its ongoing forecasts of Avidity Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Avidity Biosciences' closest peers. If more than one evaluation category is relevant for Avidity Biosciences we suggest using both methods to arrive at a better estimate.
Avidity Biosciences Cash |
|
Avidity Valuation Trend
Comparing Avidity Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Avidity Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Avidity Biosciences Total Value Analysis
Avidity Biosciences is at this time estimated to have company total value of 3.5 B with market capitalization of 5.08 B, debt of 9.85 M, and cash on hands of 398.22 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Avidity Biosciences fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.5 B | 5.08 B | 9.85 M | 398.22 M |
Avidity Biosciences Investor Information
About 95.0% of the company shares are owned by institutional investors. The book value of Avidity Biosciences was at this time reported as 12.64. The company recorded a loss per share of 2.88. Avidity Biosciences had not issued any dividends in recent years. Based on the key indicators related to Avidity Biosciences' liquidity, profitability, solvency, and operating efficiency, Avidity Biosciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Avidity Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Avidity Biosciences has an asset utilization ratio of 1.52 percent. This suggests that the Company is making $0.0152 for each dollar of assets. An increasing asset utilization means that Avidity Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Avidity Biosciences Ownership Allocation
The majority of Avidity Biosciences outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Avidity Biosciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Avidity Biosciences. Please pay attention to any change in the institutional holdings of Avidity Biosciences as this could imply that something significant has changed or is about to change at the company.Avidity Biosciences Profitability Analysis
The company reported the last year's revenue of 9.56 M. Reported Net Loss for the year was (212.22 M) with loss before taxes, overhead, and interest of (141.18 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Avidity Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Avidity Biosciences and how it compares across the competition.
About Avidity Biosciences Valuation
The stock valuation mechanism determines Avidity Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Avidity Biosciences. We calculate exposure to Avidity Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avidity Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -181.4 M | -172.3 M | |
| Pretax Profit Margin | (22.20) | (23.31) | |
| Operating Profit Margin | (24.64) | (25.88) | |
| Net Loss | (22.20) | (23.31) | |
| Gross Profit Margin | (18.98) | (18.03) |
Avidity Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 73 M |
Avidity Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Avidity Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Avidity we look at many different elements of the entity such as Avidity's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Avidity Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Avidity Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Avidity Biosciences' worth.Complementary Tools for Avidity Stock analysis
When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |